Chemoradiation in oesophageal cancer

Best Practice & Research. Clinical Gastroenterology
Tong Dai, Manish A Shah

Abstract

Oesophageal cancer is the 8th most common cancer worldwide, and has significant mortality and morbidity rates. The two most common histological types, squamous cell carcinoma and adenocarcinoma, have different localizations, distinctive risk factors, and molecular mechanisms. Survival for patients with locoregional oesophageal cancer is poor when treated with surgery only, with 5-year survival less than 10-15%. Radiation therapy has limited efficacy when given alone. Concurrent chemoradiation improves local-regional control and facilitates margin-free resection when delivered preoperatively. Chemoradiation prolongs survival when given as definitive treatment or combined with surgery. Neoadjuvant chemoradiation also reduces risk of distant recurrence. To date, there is no data supporting the addition of targeted therapy to concurrent chemoradiation. Understanding molecular pathways regulating both radiosensitivity and tumorigenesis/invasion may lead to the discovery of new targeted agents, improving outcome of chemoradiation in terms of both locoregional and systemic control, ultimately resulting in prolonged survival.

References

Aug 15, 1996·The New England Journal of Medicine·T N WalshT P Hennessy
Dec 31, 1998·The New England Journal of Medicine·D P KelsenJ A Roth
Jul 24, 2001·The Annals of Thoracic Surgery·J B HulscherJ J van Lanschot
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D MinskyDavid P Kelsen
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael StahlHansjochen Wilke
Sep 15, 2005·International Journal of Cancer. Journal International Du Cancer·Mitsuhiko HanawaAkishi Ooi
Jul 11, 2006·The New England Journal of Medicine·David Cunningham MAGIC Trial Participants
Nov 14, 2006·International Journal of Radiation Oncology, Biology, Physics·Howard SafranTeresa Kennedy
Feb 27, 2007·The Journal of Thoracic and Cardiovascular Surgery·Bryan F MeyersUNKNOWN American College of Surgeons Oncology Group Z0060
Apr 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurent BedenneChristine Binquet
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel TepperRobert Mayer
Mar 12, 2008·World Journal of Gastroenterology : WJG·Srinivas-R PuliMainor-R Antillon
Jun 25, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jaffer A AjaniChristopher G Willett
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael StahlHansjochen Wilke
Sep 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William H AllumRuth E Langley
Mar 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc YchouPhilippe Rougier
Apr 7, 2011·Nature Reviews. Clinical Oncology·Alicia OkinesIan Chau
Jun 18, 2011·International Journal of Cancer. Journal International Du Cancer·Aaron P ThriftDavid C Whiteman
Jun 21, 2011·The Lancet Oncology·Katrin M SjoquistUNKNOWN Australasian Gastro-Intestinal Trials Group
Jun 1, 2012·The New England Journal of Medicine·P van HagenUNKNOWN CROSS Group
Jun 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y Y JanjigianS-E Al-Batran
Jul 31, 2012·Biochemical and Biophysical Research Communications·Guanyu WangQinghua Dong
Aug 11, 2012·Cancer Discovery·Nishant AgrawalStephen J Meltzer
Oct 5, 2012·International Journal of Cancer. Journal International Du Cancer·Bradley J KendallUNKNOWN Study of Digestive Health
Dec 5, 2012·Seminars in Radiation Oncology·Joseph M PepekBrian G Czito
Feb 5, 2013·Lancet·Arjun PennathurJames D Luketich
Mar 16, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·S GwynneT Crosby
Mar 28, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hironobu ShigakiHideo Baba
Apr 23, 2013·Current Problems in Surgery·David Estores, Vic Velanovich
Aug 27, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J A AjaniS G Swisher
Sep 10, 2013·Current Opinion in Cell Biology·Céline Bruyère, Laurent Meijer
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vera OppedijkMaarten C C M Hulshof
Feb 5, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J HoningG A P Hospers
Feb 22, 2014·The Lancet Oncology·Thierry ConroyUNKNOWN Fédération Francophone de Cancérologie Digestive and UNICANCER-GI Group

❮ Previous
Next ❯

Citations

Dec 10, 2016·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Zhijun LiJianmin Kong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.